Showing Funds Performance since Sep 07, 2020

| Duration | Fund Return(%) | Category Average(%) | Category Best(%) |
|---|---|---|---|
| 1M | 6.34 | 0.75 | 6.46 |
| 6M | 13.69 | 2.36 | 19.11 |
| 1Y | 12.42 | 4.94 | 17.67 |
| 3Y | 22.05 | 13.84 | 104.47 |
DSP Healthcare Fund Growth managed by DSP Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹3,514 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 1.97. Under the expert guidance of Chirag Dagli ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.
Mr. Chirag Dagli holds Chartered Accountant (ICAI India) and also holds a Bachelor of Commerce Degree. Chirag has also worked with HDFC AMC Limited, Aviva life Insurance, ICICI Securities, Infinity.com Financial Services Limited, Global Markets - Deutsche Equities India Private Limited, Citigroup Global Markets India Private Limited and ICICI Securities.
| Fund Name | Ratings | AUM | Expense Ratio |
|---|---|---|---|
| Tata India Pharma & HealthCare Fund Growth | 2 | 1455.16 CR | 2.25 |
| LIC MF Healthcare Fund Growth | 1 | 92.55 CR | 2.84 |
| DSP Healthcare Fund Growth | 3 | 3514.02 CR | 1.97 |
| ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth | 5 | 6624.58 CR | 2.1 |
| UTI Healthcare Fund Growth | 3 | 1307.98 CR | 2.26 |
| Fund Name | 1Y | 3Y |
|---|---|---|
| This FundTata India Pharma & HealthCare Fund Growth | 8.8076 | 78.3132 |
| This FundLIC MF Healthcare Fund Growth | 11.243 | 80.1681 |
| This FundDSP Healthcare Fund Growth | 12.4169 | 81.813 |
| This FundICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth | 8.8833 | 96.1573 |
| This FundUTI Healthcare Fund Growth | 14.747 | 98.543 |